<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-09T09:21:46+00:00">
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MLI-C-ARC-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Improving access to HIV and TB testing and treatment for key and at risk populations in Mali - Mali (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Mali, TB/HIV, Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </description>
    <description type="2">
      <narrative>Goals: TB : Réduire l’incidence liée au TB de 30% d’ici 2025 (par rapport à l’année 2018)/ TB: Reduce TB incidence by 30% by 2025 (compared to 2018); TB : Réduire la mortalité et la morbidité liées au TB de 50% d’ici 2025 (par rapport à l’année 2018)/ Reduce TB mortality and morbidity by 50% by 2025 (compared to 2018); VIH : Réduire l’incidence liée au VIH de 50% d’ici 2025  (par rapport à l’année 2019)/HIV: Reduce HIV-related incidence by 50% by 2025 (compared to 2019); VIH : Réduire la mortalité et la morbidité liées au VIH de 50% d’ici 2025 (par rapport à l’année 2019)/HIV: Reduce HIV-related mortality and morbidity by 50% by 2025 (compared to 2019); VIH/TB :  Les principes de droits humains et d’égalité femmes-hommes sont mis en œuvre dans le cadre du plan intégré d'ici 2023/HIV / TB: The principles of human rights and gender equality are implemented in the framework of the integrated plan by 2023; VIH/TB :  La gouvernance de la riposte nationale aux VIH, TB et hépatites virales est intégrée, efficiente et performante d’ici 2023 /HIV / TB: the governance of the national response to HIV, TB and viral hepatitis is integrated, efficient and effective by 2023. Objectives: TB : Au moins 90% des cas de TB attendus sont notifiés d’ici 2025/ TB: At least 90% of expected TB cases are notified by 2025; TB : 48% des cas attendus de TB bactériologiquement confirmés, résistants aux médicaments TB-RR et/ou TB-MR sont mis sous traitement d'ici 2023/TB: 48% of expected cases of bacteriologically confirmed TB, resistant to TB-RR drugs and / or MDR-TB are started on treatment by 2023; TB : 90% des cas de co-infection TB/VIH toutes formes (nouveaux cas + rechutes) sont traitées avec succès d'ici 2023/TB: 90% of all forms of TB / HIV co-infection (new cases + relapses) are successfully treated by 2023; VIH : En 2025, 50% des adolescent(e)s et jeunes âgés de 10 à 24 ans et des populations vulnérables disposent de compétences adaptées pour se protéger du VIH et des IST par une approche différenciée de prévention et de dépistage selon l’âge et le sexe/HIV: In 2025, 50% of adolescents and young people aged 10 to 24 and vulnerable populations have the appropriate skills to protect themselves from HIV and STIs thanks to an approach to prevention and screening differentiated by age and sex; VIH : 95% des adolescent(e)s et les femmes enceintes de 15 à 49 ans connaissent leur statut sérologique pour le VIH et bénéficient du paquet minimum de prévention VIH dès l’entrée en CPN d'ici 2023/HIV: 95% of adolescents and pregnant women aged 15 to 49 know their HIV status and benefit from the minimum HIV prevention package upon entering ANC by 2023; VIH : 95% des populations clés et vulnérables (PS, HSH, UDI et transgenre) utilisent le paquet de services de prévention combinée selon des approches différenciées d'ici 2023./HIV: 95% of key and vulnerable populations SW, MSM, IDU and transgender) use the package of combined prevention services according to a  differentiated approach by 2023; VIH : 95% des PVVIH femmes et hommes connaissant leur statut reçoivent un traitement antirétroviral/HIV: 95% of PLWHIV, both women and men, who know their status receive antiretroviral therapy; VIH/TB : D'ici 2025, l’environnement social et juridique protège les personnes touchées par le VIH/TB/HV et les populations vulnérables contre la stigmatisation et la discrimination / HIV/TB: By 2025, the social and legal environment protects people affected by HIV/TB/HIV and vulnerable populations from stigma and discrimination; VIH/TB : La coordination, le leadership, le suivi-évaluation des activités et la recherche sont assurés à travers des études pour le VIH/Sida et la Tuberculose pour l’atteinte des résultats du PSNI d'ici 2023/HIV / TB: the coordination, leadership, monitoring and evaluation of activities and research are ensured by studies on HIV / AIDS and Tuberculosis to achieve the results set by the Integrated Natinal Strategic Programme by 2023.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </participating-org>
    <other-identifier ref="MLI-C-ARCP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ML" percentage="100">
      <narrative>Mali</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="64.84">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="32.51">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="2.65">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="2f83940f-3956-46e3-aeb4-0a2b2ee56af3" percentage="0.46">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="f83bbdd0-a94f-473b-9cc3-ae8a59141348" percentage="0.69">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="1e10e245-2f3d-48cc-8d98-b02bf369e956" percentage="1.21">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
        </description>
      </budget-item>
      <budget-item code="3c4ea764-548b-44a2-9605-603566cfcdf9" percentage="2.33">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 2: Preventing unintended pregnancies among women living with HIV</narrative>
        </description>
      </budget-item>
      <budget-item code="8cc23209-2129-4c18-b058-a4c3a63b6ae4" percentage="0.61">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
        </description>
      </budget-item>
      <budget-item code="c4df5dc6-61af-4f19-a9db-1c6cd15116c2" percentage="0.21">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
        </description>
      </budget-item>
      <budget-item code="88657fe2-2942-4159-860a-af9e84e64238" percentage="4.72">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="e60fdd71-5159-45b8-b0e5-887e3c84eba3" percentage="0.61">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Community empowerment</narrative>
        </description>
      </budget-item>
      <budget-item code="b0f7e056-b292-405c-81ee-0e3d059dde00" percentage="3.42">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Condom and lubricant programming</narrative>
        </description>
      </budget-item>
      <budget-item code="d114003b-2059-4703-bbdf-e540a4be0418" percentage="3.12">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Harm reduction interventions for drug use</narrative>
        </description>
      </budget-item>
      <budget-item code="1eaf7f29-1761-46e4-90fd-cce9b9c1bbea" percentage="0.36">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Linkages between HIV programs and RMNCAH</narrative>
        </description>
      </budget-item>
      <budget-item code="61bfa00d-5158-4201-9e12-b91bee129c91" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="e2860998-43fe-4145-aabf-08302069b9f1" percentage="1.89">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
        </description>
      </budget-item>
      <budget-item code="06f7d2bb-99d8-4c7b-95d2-bc02c0b90b93" percentage="0.05">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="0597f88b-5b88-4b47-8d91-6f7889b4f36f" percentage="0.48">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
        </description>
      </budget-item>
      <budget-item code="56595a18-f1ed-4f39-8c05-d687d5911e6b" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="fe7b40b4-5c8d-41e2-b78b-e98fa68cabe7" percentage="0.26">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights" campaign)</narrative>
        </description>
      </budget-item>
      <budget-item code="3980356a-cb5d-41ef-9ac0-654bcf4991e7" percentage="0.16">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="9476a49e-917c-4607-b0d3-5ccee13653a6" percentage="2.81">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="b0eb178f-7923-4f1d-a0dc-04aed075b79a" percentage="8.99">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="0.3">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="61.7">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="ea41b061-34f4-4f5f-b2d7-d7e7838c9c59" percentage="0.83">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Routine grant financial management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.1">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="1.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="0.72">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="1.65">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="a87c4f51-0287-43c7-9064-8f92833da8c6" percentage="0.66">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="0.25">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">7705185.49</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">8625326.26</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">10603778.80</value>
    </budget>
    <capital-spend percentage="4.62" />
    <transaction ref="acd26399-b975-47e3-9a48-ef40d618449c">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-18" />
      <value currency="USD" value-date="2021-01-18">16661854.56</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9df605c2-bb67-4221-8f59-749f28b99f4d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-20" />
      <value currency="USD" value-date="2021-01-20">2022495.69</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fabf6893-c742-4e68-b846-35e63c2a71c7">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">384753.95</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ea5b158f-a822-4343-8b4e-4c1c24cc06fd">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">507337.87</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="360d0033-ad29-454e-afb7-3b7791f08cfe">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">399306.55</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="434ffea7-eea0-4b80-8e8a-8e990799e05e">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">476093.01</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4e12a1c0-548f-4e0b-a9f0-668c7077535f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-26" />
      <value currency="USD" value-date="2021-03-26">358815.02</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2336d374-a758-41ed-9fc0-e7ef62e55aaf">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-02" />
      <value currency="USD" value-date="2021-04-02">337164.11</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="87589e8f-0191-4122-85fd-61e84327ff0f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-16" />
      <value currency="USD" value-date="2021-09-16">18766.96</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f4dfbb4e-6c0a-4466-8951-89a06814b99f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-23" />
      <value currency="USD" value-date="2021-09-23">1405697.13</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cf17d4de-04d9-4183-abf9-2c165b235b78">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-28" />
      <value currency="USD" value-date="2021-10-28">507337.03</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="83b3a986-6ba3-42a5-8bf3-18393137cc13">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-28" />
      <value currency="USD" value-date="2021-10-28">399305.93</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4773a841-7b4c-4b7d-8d01-1f65f663b8c5">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-28" />
      <value currency="USD" value-date="2021-10-28">384753.58</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9644d587-8615-4c4e-a7dd-be32881d039b">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">1203667.35</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ee2ffaa4-837b-42b2-9575-00c192709d6e">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">15975.49</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c4d54f1b-577b-4ac8-8fa5-7b36f797ff19">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">245958.20</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="73f9132e-be32-4505-a0a7-3750d01878f4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">301350.02</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f310d13-23aa-4607-a5e2-2e1053be8a2d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">6881.38</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="db96db01-6559-40ce-9d7b-927c85e661e1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-24" />
      <value currency="USD" value-date="2022-02-24">27613.83</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ee4424ec-5252-4525-ba7f-c20afdbdd691">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-24" />
      <value currency="USD" value-date="2022-03-24">178195.94</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f633e58-4260-48d8-ad47-0857c1716c7e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-21" />
      <value currency="USD" value-date="2022-04-21">1263781.06</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="384e8aa1-ffcc-4994-a2e4-861e80029497">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-21" />
      <value currency="USD" value-date="2022-04-21">387403.63</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="75d8e25c-0cb6-4df7-bbdf-78760e9be381">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-07" />
      <value currency="USD" value-date="2022-07-07">631703.29</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3055ea9-54d3-4c14-92b3-1f07c4e6a2cb">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-07" />
      <value currency="USD" value-date="2022-07-07">254937.41</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="29f0e248-3567-42af-a3af-4173ea68397b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-07" />
      <value currency="USD" value-date="2022-07-07">9967.86</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d2a3aa47-34a4-452e-a9ba-8da8cf17c529">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-21" />
      <value currency="USD" value-date="2022-07-21">1379446.78</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="45459593-9361-43e9-babf-a50f754f2521">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-21" />
      <value currency="USD" value-date="2022-07-21">64782.36</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a688d6db-717d-4b87-98b5-cfbb0250b4c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-21" />
      <value currency="USD" value-date="2022-07-21">192653.23</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e408a48f-9f9f-4b90-9745-5920144e4673">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">550114.95</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c5611181-3d02-4eaa-a2ee-d8b0bece4fa8">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">60900.47</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8fabd331-a173-4b82-9f69-fa28b8cd9aa3">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">434452.74</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9497cb56-922b-4f66-9134-1ac0f5b603fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">10896.70</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7415d9b8-79da-413d-b7b7-c01ad22a6fd7">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">492137.54</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1abbe575-743b-4b2f-b274-e05953b1dfc7">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">182880.66</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2fd3ad75-307d-4e1c-84a9-ae773e16598b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">349479.87</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c89d63c8-5aad-4d05-a352-f8b68110a311">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-03" />
      <value currency="USD" value-date="2022-11-03">-1214846.99</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1223b081-5f39-4189-a83e-dad2787c50de">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-03" />
      <value currency="USD" value-date="2022-11-03">5752539.46</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d016f84-8eeb-439e-8ede-efa9f69d64f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-08" />
      <value currency="USD" value-date="2022-11-08">46303.19</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="88d89663-fc05-40f4-9066-60a5edf26fde">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-08" />
      <value currency="USD" value-date="2022-11-08">535226.90</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="07e3b84d-dd22-4944-a750-7a91b92a0559">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-08" />
      <value currency="USD" value-date="2022-11-08">20157.72</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="99708fbe-b03c-4e79-adfa-82f5cad740f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-24" />
      <value currency="USD" value-date="2022-11-24">255697.35</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b6bd03f6-105c-476f-b012-cd272f358b3f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-14" />
      <value currency="USD" value-date="2023-02-14">1643974.53</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="03088ee4-a39b-43a2-b0ea-30a62b3645ce">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-14" />
      <value currency="USD" value-date="2023-02-14">39634.28</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f9d4fc82-92e8-4fbd-8d1f-59b23308b414">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">216598.50</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e20659f2-287a-4090-bcd7-3949daa4e5d7">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">252749.96</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="623812cf-7ae1-4524-a3f1-d2315b391279">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">309647.45</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0c16aa02-ff1e-48b5-bff8-c750206ea63a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">141140.36</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="65922424-3eea-4eea-b668-4f6474b3e9ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-02" />
      <value currency="USD" value-date="2023-05-02">43015.96</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3ecf60d4-9e88-4f38-b5ac-a263e8b84627">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-04" />
      <value currency="USD" value-date="2023-05-04">1273952.80</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="15e26bc7-32e7-413a-a61d-9d625c7a6ddf">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-13" />
      <value currency="USD" value-date="2023-06-13">15280.03</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="64e35fcb-90c3-4c2c-b9aa-bc64e4cc0baf">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-22" />
      <value currency="USD" value-date="2023-06-22">299042.39</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4d4a6820-d21a-4457-b292-7ea455917cda">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-13" />
      <value currency="USD" value-date="2023-07-13">-660118.03</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ef8e4730-f2a0-4359-9f73-3922da31f38f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-13" />
      <value currency="USD" value-date="2023-07-13">5484678.03</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cffa6394-0e0d-4563-8199-4713c6771d53">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">22103.14</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="af37233e-8e93-4929-886a-ccbf0889fcba">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">29640.02</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="31b8a620-d3de-4a6b-954e-0a40c67e5905">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">27218.47</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c81effda-5056-4c6c-b1ec-2fec213bb14b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-03" />
      <value currency="USD" value-date="2023-08-03">1620191.14</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="66b317d4-0334-4127-b546-98019add8a99">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-03" />
      <value currency="USD" value-date="2023-08-03">47533.34</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a67609c4-0e03-48d7-8660-fe255ecbacf8">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-15" />
      <value currency="USD" value-date="2023-08-15">330888.44</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d82d7e09-7314-4bb8-8c35-8ba6c241dff2">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">15142.16</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1e47baf1-883b-4b7c-a075-c8f8097fac1f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">309681.80</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fc610712-bad5-4eb6-ac5e-6c49904a0b88">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-06" />
      <value currency="USD" value-date="2023-11-06">49225.17</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6763ec8d-d3b2-484b-bd8a-58a8e4af314b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-06" />
      <value currency="USD" value-date="2023-11-06">1686890.84</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e9067c7f-279e-4d74-b537-65a0c6ea92f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-06" />
      <value currency="USD" value-date="2023-11-06">254179.12</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f487855c-1e7d-458a-abdd-6f472c9b7619">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-06" />
      <value currency="USD" value-date="2023-11-06">24784.97</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b015d599-de1e-44a8-9a4a-aef4f1a94a62">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-16" />
      <value currency="USD" value-date="2023-11-16">281961.21</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="13eb7eaf-f22b-4237-b3e6-c3bb848bfcbe">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-20" />
      <value currency="USD" value-date="2024-02-20">26275.85</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="abbf5afc-7711-4728-995f-e40e3121c4c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-18" />
      <value currency="USD" value-date="2024-04-18">61997.46</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8f23504f-9652-487d-ab4f-a7566efeba33">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-06-01" />
      <value currency="USD" value-date="2024-06-01">558.09</value>
      <description>
        <narrative>Funds returned to the Global Fund from MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="066417b8-1978-4cc5-ba80-c8447e3b4dc0">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-06-01" />
      <value currency="USD" value-date="2024-06-01">1201.31</value>
      <description>
        <narrative>Funds returned to the Global Fund from MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5671f22-aba0-499b-93a7-cacf4bdd8b43">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-07" />
      <value currency="USD" value-date="2024-06-07">-1201.31</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="134dca56-1deb-4622-823a-1cb3f22ed692">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-07" />
      <value currency="USD" value-date="2024-06-07">-558.09</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3425b34d-73bd-4933-a163-f1fd6a242f25">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-02" />
      <value currency="USD" value-date="2024-07-02">245085.76</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9a382d8b-a336-4e87-b9e2-8d5b2d09f0aa">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-17" />
      <value currency="USD" value-date="2024-10-17">495916.88</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2d9c8563-4bf0-4480-b927-d1181ba56a69">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-17" />
      <value currency="USD" value-date="2024-10-17">-451879.16</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d50924b9-ea79-4b26-a119-deb95bbd1f49">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-22" />
      <value currency="USD" value-date="2024-10-22">14422.75</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5179e30a-1e7f-4433-b5cb-3c5a9977c54d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-22" />
      <value currency="USD" value-date="2024-10-22">29836.41</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0db6cf16-7bcf-4a02-ad78-5e19872262c6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-10" />
      <value currency="USD" value-date="2025-11-10">-253903.93</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="610258b7-4d4a-4699-898c-a8e5119e3c15">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">253903.93</value>
      <description>
        <narrative>Funds returned to the Global Fund from MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="69e1e14a-39fe-476c-938c-cd83d3ffa686">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-16" />
      <value currency="USD" value-date="2026-04-16">-451657.72</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="MLI-C-ARCP01-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">7704923.79</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP01, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MLI-C-ARCP01-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">8527420.75</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP01, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MLI-C-ARCP01-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">8655737.01</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP01, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MLI-C-ARCP01-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">487115.43</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP01, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MLI-C-ARC" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MLI/2020/Multicomponent/en/MLI-Z_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2c - Multicomponent - Mali - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR780-MLI-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-06-30" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MLI/2020/Multicomponent/fr/MLI-Z_FundingRequest_1_fr.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2c - Multicomponent - Mali - Français</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR780-MLI-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="fr" />
      <document-date iso-date="2020-06-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-5-Other1 Percentage of sex workers newly diagnosed with HIV initiated on ART</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-5-Other1 Percentage of sex workers newly diagnosed with HIV initiated on ART</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="79.97">
          <comment>
            <narrative>Numerator: 463; Denominator: 579.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="84.9">
            <comment>
              <narrative>Numerator: 880; Denominator: 1036.</narrative>
            </comment>
          </target>
          <actual value="59.2">
            <comment>
              <narrative>Numerator: 750; Denominator: 1267.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="84.94">
            <comment>
              <narrative>Numerator: 440; Denominator: 518.</narrative>
            </comment>
          </target>
          <actual value="35.7">
            <comment>
              <narrative>Numerator: 185; Denominator: 518.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="84.94">
            <comment>
              <narrative>Numerator: 440; Denominator: 518.</narrative>
            </comment>
          </target>
          <actual value="75.4">
            <comment>
              <narrative>Numerator: 565; Denominator: 749.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 1030; Denominator: 1170.</narrative>
            </comment>
          </target>
          <actual value="77.4">
            <comment>
              <narrative>Numerator: 1425; Denominator: 1840.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="88.03">
            <comment>
              <narrative>Numerator: 515; Denominator: 585.</narrative>
            </comment>
          </target>
          <actual value="77">
            <comment>
              <narrative>Numerator: 681; Denominator: 884.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="88.03">
            <comment>
              <narrative>Numerator: 515; Denominator: 585.</narrative>
            </comment>
          </target>
          <actual value="77.8">
            <comment>
              <narrative>Numerator: 744; Denominator: 956.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90.1">
            <comment>
              <narrative>Numerator: 1162; Denominator: 1290.</narrative>
            </comment>
          </target>
          <actual value="82.7">
            <comment>
              <narrative>Numerator: 1753; Denominator: 2119.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90.08">
            <comment>
              <narrative>Numerator: 581; Denominator: 645.</narrative>
            </comment>
          </target>
          <actual value="82.7">
            <comment>
              <narrative>Numerator: 870; Denominator: 1052.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90.08">
            <comment>
              <narrative>Numerator: 581; Denominator: 645.</narrative>
            </comment>
          </target>
          <actual value="82.8">
            <comment>
              <narrative>Numerator: 883; Denominator: 1067.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-5-Other2 Percentage of MSM newly diagnosed with HIV initiated on ART</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-5-Other2 Percentage of MSM newly diagnosed with HIV initiated on ART</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="82.17">
          <comment>
            <narrative>Numerator: 212; Denominator: 258.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="85.8">
            <comment>
              <narrative>Numerator: 139; Denominator: 162.</narrative>
            </comment>
          </target>
          <actual value="42">
            <comment>
              <narrative>Numerator: 68; Denominator: 162.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="85.8">
            <comment>
              <narrative>Numerator: 279; Denominator: 325.</narrative>
            </comment>
          </target>
          <actual value="72.4">
            <comment>
              <narrative>Numerator: 299; Denominator: 413.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="85.89">
            <comment>
              <narrative>Numerator: 140; Denominator: 163.</narrative>
            </comment>
          </target>
          <actual value="92">
            <comment>
              <narrative>Numerator: 231; Denominator: 251.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="88.82">
            <comment>
              <narrative>Numerator: 151; Denominator: 170.</narrative>
            </comment>
          </target>
          <actual value="87.4">
            <comment>
              <narrative>Numerator: 160; Denominator: 183.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="88.9">
            <comment>
              <narrative>Numerator: 303; Denominator: 341.</narrative>
            </comment>
          </target>
          <actual value="90.3">
            <comment>
              <narrative>Numerator: 353; Denominator: 391.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="88.89">
            <comment>
              <narrative>Numerator: 152; Denominator: 171.</narrative>
            </comment>
          </target>
          <actual value="92.8">
            <comment>
              <narrative>Numerator: 193; Denominator: 208.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="91.53">
            <comment>
              <narrative>Numerator: 162; Denominator: 177.</narrative>
            </comment>
          </target>
          <actual value="90.1">
            <comment>
              <narrative>Numerator: 246; Denominator: 273.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="91.5">
            <comment>
              <narrative>Numerator: 325; Denominator: 355.</narrative>
            </comment>
          </target>
          <actual value="88.1">
            <comment>
              <narrative>Numerator: 468; Denominator: 531.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="91.57">
            <comment>
              <narrative>Numerator: 163; Denominator: 178.</narrative>
            </comment>
          </target>
          <actual value="86">
            <comment>
              <narrative>Numerator: 222; Denominator: 258.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 338; Denominator: 7413; Percentage: 4.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 329.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 329.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 329.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 329.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6180; Denominator: 8267; Percentage: 74.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4587; Denominator: 8267; Percentage: 55.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5562; Denominator: 8267; Percentage: 67.28%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 546; Denominator: 8267; Percentage: 6.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 543.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6180; Denominator: 8267; Percentage: 74.76%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4587; Denominator: 8267; Percentage: 55.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5799; Denominator: 8730; Percentage: 66.43%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5460; Denominator: 8730; Percentage: 62.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6443; Denominator: 8730; Percentage: 73.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6288; Denominator: 8730; Percentage: 72%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6443; Denominator: 8730; Percentage: 73.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6288; Denominator: 8730; Percentage: 72%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 6262.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5990; Denominator: 9219; Percentage: 64.97%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5430; Denominator: 9219; Percentage: 58.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 5384.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 46.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6655; Denominator: 9219; Percentage: 72.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6061; Denominator: 9219; Percentage: 65.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6655; Denominator: 9219; Percentage: 72.19%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6061; Denominator: 9219; Percentage: 65.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 6036.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="4917" />
        <baseline year="2019" iso-date="2019-12-31" value="4765">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="4765">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="4765">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="4765">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="152">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="152">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="152">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="152">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="4870" />
          <actual value="2621" />
          <actual value="2542">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="79">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5411" />
          <actual value="5183" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5411" />
          <actual value="5183" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5676" />
          <actual value="5839" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="5449" />
          <actual value="5503" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5676" />
          <actual value="5839" />
          <actual value="5631">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="208">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="5827" />
          <actual value="5911" />
          <actual value="5638">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="273">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5946" />
          <actual value="6193" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5946" />
          <actual value="6193" />
          <actual value="5935">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="258">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 8211; Denominator: 77794; Percentage: 10.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 8119.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 8119.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 8119.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 8119.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 92.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 92.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 92.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 92.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 11581; Denominator: 25736; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4534; Denominator: 25736; Percentage: 17.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 4468.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 66.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12868; Denominator: 25736; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12460; Denominator: 25736; Percentage: 48.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12868; Denominator: 25736; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12460; Denominator: 25736; Percentage: 48.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 21165; Denominator: 47033; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19073; Denominator: 47033; Percentage: 40.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23517; Denominator: 47033; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19920; Denominator: 47033; Percentage: 42.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23517; Denominator: 47033; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19920; Denominator: 47033; Percentage: 42.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 19679.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 241.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 34113; Denominator: 75805; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24733; Denominator: 75805; Percentage: 32.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 24440.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 293.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 37903; Denominator: 75805; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31827; Denominator: 75805; Percentage: 42%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 37903; Denominator: 75805; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31827; Denominator: 75805; Percentage: 42%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 31434.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 393.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 846; Denominator: 2686; Percentage: 31.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 831.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 831.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 831.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 831.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 15.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 15.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 15.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 15.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1054; Denominator: 4928; Percentage: 21.39%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 949; Denominator: 4928; Percentage: 19.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 928.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 21.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1110; Denominator: 4928; Percentage: 22.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1592; Denominator: 4928; Percentage: 32.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1110; Denominator: 4928; Percentage: 22.52%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1592; Denominator: 4928; Percentage: 32.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1859; Denominator: 5162; Percentage: 36%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2140; Denominator: 5162; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1805; Denominator: 5162; Percentage: 34.97%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2037; Denominator: 5162; Percentage: 39.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1859; Denominator: 5162; Percentage: 36.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2140; Denominator: 5162; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2098.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2242; Denominator: 5348; Percentage: 41.92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2653; Denominator: 5348; Percentage: 49.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2593.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 60.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2309; Denominator: 5348; Percentage: 43.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2878; Denominator: 5348; Percentage: 53.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2309; Denominator: 5348; Percentage: 43.18%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2878; Denominator: 5348; Percentage: 53.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2801.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 77.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 14552; Denominator: 20165; Percentage: 72.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 13970.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 13970.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 13970.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 13970.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 582.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 582.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 582.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 582.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 15537; Denominator: 20891; Percentage: 74.37%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7770; Denominator: 20891; Percentage: 37.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 7503.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 267.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17263; Denominator: 20891; Percentage: 82.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17205; Denominator: 20891; Percentage: 82.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17263; Denominator: 20891; Percentage: 82.63%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17205; Denominator: 20891; Percentage: 82.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 17619; Denominator: 21664; Percentage: 81.33%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21620; Denominator: 21664; Percentage: 99.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 19493; Denominator: 21664; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21840; Denominator: 21664; Percentage: 100.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 19493; Denominator: 21664; Percentage: 89.98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21840; Denominator: 21664; Percentage: 100.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 20884.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 956.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 21496; Denominator: 22422; Percentage: 95.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 22634; Denominator: 22422; Percentage: 100.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 19775; Denominator: 22422; Percentage: 88.19%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 22063; Denominator: 22422; Percentage: 98.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 21011.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1052.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 21496; Denominator: 22422; Percentage: 95.87%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 22634; Denominator: 22422; Percentage: 100.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 21567.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1067.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="16.11">
          <comment>
            <narrative>Numerator: 58; Denominator: 360.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="20.98">
            <comment>
              <narrative>Numerator: 113.1; Denominator: 539.</narrative>
            </comment>
          </target>
          <actual value="15.6">
            <comment>
              <narrative>Numerator: 84; Denominator: 539.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="23.3">
            <comment>
              <narrative>Numerator: 125.6; Denominator: 539.</narrative>
            </comment>
          </target>
          <actual value="37.3">
            <comment>
              <narrative>Numerator: 201; Denominator: 539.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="23.3">
            <comment>
              <narrative>Numerator: 125.58; Denominator: 539.</narrative>
            </comment>
          </target>
          <actual value="37.3">
            <comment>
              <narrative>Numerator: 201; Denominator: 539.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="28.94">
            <comment>
              <narrative>Numerator: 162.36; Denominator: 561.</narrative>
            </comment>
          </target>
          <actual value="36">
            <comment>
              <narrative>Numerator: 202; Denominator: 561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="32.2">
            <comment>
              <narrative>Numerator: 180.4; Denominator: 561.</narrative>
            </comment>
          </target>
          <actual value="39.2">
            <comment>
              <narrative>Numerator: 220; Denominator: 561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="32.16">
            <comment>
              <narrative>Numerator: 180.4; Denominator: 561.</narrative>
            </comment>
          </target>
          <actual value="39.2">
            <comment>
              <narrative>Numerator: 220; Denominator: 561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="37.32">
            <comment>
              <narrative>Numerator: 217.58; Denominator: 583.</narrative>
            </comment>
          </target>
          <actual value="43.1">
            <comment>
              <narrative>Numerator: 251; Denominator: 582.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="41.5">
            <comment>
              <narrative>Numerator: 241.7; Denominator: 583.</narrative>
            </comment>
          </target>
          <actual value="47.2">
            <comment>
              <narrative>Numerator: 275; Denominator: 583.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="41.45">
            <comment>
              <narrative>Numerator: 241.66; Denominator: 583.</narrative>
            </comment>
          </target>
          <actual value="47.2">
            <comment>
              <narrative>Numerator: 275; Denominator: 583.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="5204" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="5126" />
          <actual value="2772" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5696" />
          <actual value="5243" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5696" />
          <actual value="5243" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="5736" />
          <actual value="5521" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5975" />
          <actual value="5839" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5975" />
          <actual value="5839" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="6134" />
          <actual value="5966" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="6259" />
          <actual value="6195" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="6259" />
          <actual value="6195" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 950; Denominator: 2686; Percentage: 35.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 638.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 638.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 638.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 312.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 312.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 312.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 48.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 48.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 48.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 902.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 902.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 902.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1110; Denominator: 4928; Percentage: 22.52%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 968; Denominator: 4928; Percentage: 19.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 613.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 355.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 67.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 901.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1233; Denominator: 4928; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1592; Denominator: 4928; Percentage: 32.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1233; Denominator: 4928; Percentage: 25.02%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1592; Denominator: 4928; Percentage: 32.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2065; Denominator: 5162; Percentage: 40%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2141; Denominator: 5162; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1900; Denominator: 5162; Percentage: 36.81%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2037; Denominator: 5162; Percentage: 39.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2065; Denominator: 5162; Percentage: 40%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2141; Denominator: 5162; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1445.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 696.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 154.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1987.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2360; Denominator: 5348; Percentage: 44.13%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2654; Denominator: 5348; Percentage: 49.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1790.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 864.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 221.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2433.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2565; Denominator: 5348; Percentage: 48%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2881; Denominator: 5348; Percentage: 53.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2565; Denominator: 5348; Percentage: 47.96%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2881; Denominator: 5348; Percentage: 53.9%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="77.77">
          <comment>
            <narrative>Numerator: 15682; Denominator: 20165.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 18172; Denominator: 20891.</narrative>
            </comment>
          </target>
          <actual value="83.6">
            <comment>
              <narrative>Numerator: 17457; Denominator: 20891.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="78.29">
            <comment>
              <narrative>Numerator: 16355; Denominator: 20891.</narrative>
            </comment>
          </target>
          <actual value="37.9">
            <comment>
              <narrative>Numerator: 7921; Denominator: 20891.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="86.98">
            <comment>
              <narrative>Numerator: 18172; Denominator: 20891.</narrative>
            </comment>
          </target>
          <actual value="83.6">
            <comment>
              <narrative>Numerator: 17457; Denominator: 20891.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="93.1">
            <comment>
              <narrative>Numerator: 20159; Denominator: 21664.</narrative>
            </comment>
          </target>
          <actual value="101.5">
            <comment>
              <narrative>Numerator: 21995; Denominator: 21664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="85.61">
            <comment>
              <narrative>Numerator: 18546; Denominator: 21664.</narrative>
            </comment>
          </target>
          <actual value="100.2">
            <comment>
              <narrative>Numerator: 21704; Denominator: 21664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="93.05">
            <comment>
              <narrative>Numerator: 20159; Denominator: 21664.</narrative>
            </comment>
          </target>
          <actual value="101.5">
            <comment>
              <narrative>Numerator: 21995; Denominator: 21664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="92.84">
            <comment>
              <narrative>Numerator: 20816; Denominator: 22422.</narrative>
            </comment>
          </target>
          <actual value="98.8">
            <comment>
              <narrative>Numerator: 22161; Denominator: 22422.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100.9">
            <comment>
              <narrative>Numerator: 22627; Denominator: 22422.</narrative>
            </comment>
          </target>
          <actual value="101.6">
            <comment>
              <narrative>Numerator: 22770; Denominator: 22422.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100.91">
            <comment>
              <narrative>Numerator: 22627; Denominator: 22422.</narrative>
            </comment>
          </target>
          <actual value="101.6">
            <comment>
              <narrative>Numerator: 22770; Denominator: 22422.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="67" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="47" />
          <actual value="24" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="94" />
          <actual value="70" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="47" />
          <actual value="46" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="118" />
          <actual value="117" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="59" />
          <actual value="45" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="59" />
          <actual value="72" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="71" />
          <actual value="71" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="142" />
          <actual value="154" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="71" />
          <actual value="83" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="532" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="532" />
          <actual value="466" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="266" />
          <actual value="76" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="266" />
          <actual value="390" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="674" />
          <actual value="922" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="337" />
          <actual value="397" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="337" />
          <actual value="525" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="904" />
          <actual value="867" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="452" />
          <actual value="414" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="452" />
          <actual value="453" />
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MLI-C-ARC-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Improving access to HIV and TB testing and treatment for key and at risk populations in Mali - Mali (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Mali, TB/HIV, Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </description>
    <description type="2">
      <narrative>Goals: TB : Réduire l’incidence liée à la TB d'au moins 15% d’ici 2026 (par rapport à l’année 2018) /  TB: Reduce TB incidence by at least 15% by 2026 (compared to 2018); TB : Réduire la mortalité et la morbidité liées à la TB d'au moins 40% d’ici 2026 (par rapport à l’année 2018) /  TB: Reduce TB mortality and morbidity by at least 40% by 2026 (compared to 2018); VIH : Réduire les nouvelles infections liées au VIH de 60% d’ici 2026  (par rapport à l’année 2019) / HIV: Reduce new HIV infections by 60% by 2026 (compared to 2019); VIH : Réduire les décès liés au sida de 60% d’ici 2026 (par rapport à l’année 2019) /  HIV: Reduce AIDS-related deaths by 60% by 2026 (compared to 2019); VIH/TB : Les principes de droits humains et d’égalité femmes-hommes sont mis en œuvre dans le cadre du plan intégré d'ici 2026 / HIV/TB: The principles of human rights and gender equality are implemented in the framework of the integrated plan by 2026; VIH/TB : La gouvernance de la riposte nationale aux VIH, TB et hépatites virales est intégrée, efficiente et performante d’ici 2026 / HIV/TB: The governance of the national response to HIV, TB and viral hepatitis is integrated, efficient and effective by 2026; SRPS : Contribuer à l'amélioration de l'état de santé et du bien-être de la population malienne  / RSSH: Contribute to improving the health and well-being of the Malian population. Objectives: D'ici 2026, au moins 90% des cas de TB notifiés bénéficient d'un traitement de qualité et sont traités avec succès / By 2026, at least 90% of notified TB cases benefit from quality treatment and are successfully treated; D'ici 2026, au moins 85% des cas de TB-MR sont traités avec succès / By 2026, at least 85% of MDR-TB are successfully treated; En 2026, au moins 95% des populations clés (TS, HSH, UDI, personnes transgenres et détenus) et les autres populations vulnérables utilisent le paquet de services de prévention combinée selon les approches différenciées / By 2026, at least 95% of key populations (SW, MSM, PWID, transgender persons and prisoners) and other vulnerable populations are using the combined prevention service package according to differentiated approaches; D'ici 2026, l'élimination de la transmission du VIH de la mère à l'enfant est assurée à moins de 2% / By 2026, the elimination of mother-to-child transmission of HIV is ensured at less than 2%; En 2026, 95% des PVVIH connaissent leur statut sérologique pour le VIH, grâce à la mobilisation communautaire et la mise en œuvre des approches de dépistage différenciée / By 2026, 95% of PLHIV know their HIV status, thanks to community mobilization and the implementation of differentiated testing approaches; En 2026, 95% des PVVIH connaissant leur statut reçoivent un traitement antirétroviral conforme aux directives nationales, avec la contribution actives des acteurs communautaires / By 2026, 95% of PLHIV who know their status will be receiving antiretroviral treatment in line with national guidelines, with the active contribution of community players; En 2026, 100% des PVVIH ayant une coinfection TB/VIH et IO sont traités selon les directives nationales / By 2026, 100% of PLHIV with TB/HIV and OI are treated in line with national guidelines; En 2026, l'environnement social et juridique protège les PVVIH et les populations vulnérables contre la stigmatisation et la discrimination / By 2026, the social and legal environment protects people affected by HIV/TB/HIV and vulnerable populations from stigma and discrimination; Le leadership et la coordination de la riposte nationale au VIH/sida/IST/HV sont assurés efficacement au niveau central sous la direction de la CSLS-TBH en coordination avec la DGSHP, les DRS et les entités communautaires / The leadership and coordination of the national response to HIV/AIDS/STI/HV are effectively ensured at the central level under the direction of the CSLS-TBH in coordination with the DGSHP, the DRS and community entities.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </participating-org>
    <other-identifier ref="MLI-C-ARCP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ML" percentage="100">
      <narrative>Mali</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="62.19">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="32.9">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="4.91">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="0.73">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="0.54">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="698ea3f4-346f-4df8-ab2e-c01a47bbccd9" percentage="0.48">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
        </description>
      </budget-item>
      <budget-item code="1ef60004-7321-4f53-93cf-6bdfa56924ef" percentage="0.63">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
        </description>
      </budget-item>
      <budget-item code="92423e34-c66c-47f4-9cac-58b9e0ea01fc" percentage="1.3">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.65">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="0.16">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e14e7a7d-49ce-4bb6-8454-ae4224e7a32e" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="cfd9f41e-52ee-4b8f-a55c-e416fa546878" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Community empowerment for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="52020c8d-d3b6-42f6-9137-038784523b8a" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Condom and lubricant programming for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="97e87d65-a4de-4357-81ae-2aae27b112a2" percentage="0.15">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="8a68b0fa-0674-4039-b5d0-396ae5bcf3d3" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Removing human rights-related barriers to prevention for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="09268318-342f-41af-84e1-0aab4e2fd8f3" percentage="1.56">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Community empowerment for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="1d7ecc3b-d5b9-48ca-a9e7-d8fa38cf3455" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="d4788f0c-523b-415c-b8ec-03eaa8789e31" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; HIV prevention communication, information and demand creation for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="f1547d57-4fe3-48f6-acd2-f3c9e4e016d1" percentage="0.19">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="49ef45b6-ef30-48b1-b393-f34c25d513c4" percentage="1.4">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="10c0f677-be26-46fb-a1c0-17c238f89b7e" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Removing human rights-related barriers to prevention for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="12d964e1-5c4b-4caa-9b00-225bb89861dd" percentage="4.34">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Community empowerment for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="1.07">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="394d6538-8808-4811-b96b-d6bf71843cb6" percentage="0.4">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3f39233d-f679-42ce-8532-a7949f0d93ef" percentage="1.4">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="c1c1a139-7603-46fe-a10f-3766fac53456" percentage="0.25">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Community empowerment for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="daac344e-ec8e-4193-9c8a-266fdd2e69ac" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="55ece96e-d30c-46d2-8db0-27306b249434" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="6853dd18-909c-4836-8981-2e434afc456c" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="a4e4d0e7-9dfd-49d8-8030-0f9cc9b713fc" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Prevention program stewardship -&gt; Prevention program stewardship</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="10e03ea0-16be-40e1-9fba-682edec921d0" percentage="0.15">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="ecc245de-32bf-41ff-8eb1-f5fae2eb1557" percentage="0.41">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights") (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="14.68">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.99">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="32.31">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="1.67">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="2.67">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="0e90e07b-37cc-4294-9a44-c1afd707a824" percentage="21.43">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="3.31">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="0.59">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.46">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="0.65">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcbb01c-6f63-414e-a67b-9a54f6bd04c0" percentage="0.41">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Miners and mining communities</narrative>
        </description>
      </budget-item>
      <budget-item code="1ed5e501-534e-43ae-bb9f-9552bd6bf461" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="1.08">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="8d2f8312-6339-4e40-9c64-84e09bb628b3" percentage="0.19">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Urban poor/slum dwellers</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="2.02">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">7738193.78</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">9253287.63</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">7779768.35</value>
    </budget>
    <capital-spend percentage="6.03" />
    <transaction ref="37f9a1cc-17d3-477a-8566-c428624d7148">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-02-01" />
      <value currency="USD" value-date="2024-02-01">17853805.78</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2506121a-86d0-48f1-8230-49842244831a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-06" />
      <value currency="USD" value-date="2024-02-06">2456914.83</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="10bad6f0-a50c-4a78-ac3f-d5132c224b9e">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">228555.39</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6b093264-e661-4f5f-a096-b487823a9619">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">26416.37</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="78c919ae-fc2b-4f2b-ab81-9613097311eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">118797.81</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="83496b9f-c0df-44be-a6ae-13f62f9adef4">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">260924.99</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="892facbf-8e8d-4baa-84b8-7b4ee40f0dff">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">189195.23</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5327e85b-891c-45de-88a8-dfe1cfcf1ae6">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">218531.54</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5ce08f08-d46b-40fc-abb9-8e3ede170d2d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">139456.53</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="14aa9f8d-7d5d-4a59-92aa-d1947283858c">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-23" />
      <value currency="USD" value-date="2024-07-23">2507338.10</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7415ad4b-04fd-4df3-a4db-5f276369a3ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">209986.63</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="463a1363-4564-48e9-8700-13bac56caa85">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">131092.04</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cd816ac5-1870-4aaf-8250-77e44d2815b1">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-01" />
      <value currency="USD" value-date="2024-11-01">274272.44</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2feaec8-2f51-45fb-8e88-195b00ca0bd7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-19" />
      <value currency="USD" value-date="2024-11-19">1379788.78</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4228f1cc-1716-4602-8fdd-dc345f55ee08">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-05" />
      <value currency="USD" value-date="2024-12-05">173631.55</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="565edab3-9458-4d22-9207-5018219a239b">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-13" />
      <value currency="USD" value-date="2024-12-13">38153.50</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cc89f12c-ca36-41b5-885c-2b72e63060d1">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-19" />
      <value currency="USD" value-date="2024-12-19">47471.72</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="74fb62f7-a4ba-4308-b5f1-69b302294863">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-18" />
      <value currency="USD" value-date="2025-02-18">359714.38</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8f77e7f2-133c-4876-a8be-568ba3ad45b4">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-04" />
      <value currency="USD" value-date="2025-03-04">993836.67</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9c637356-e2d6-4eb9-b8b3-ec4ef91a356d">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-04" />
      <value currency="USD" value-date="2025-03-04">191181.07</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1c787a3a-bf25-4ac6-b8b1-6f8423b51cc2">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">159026.33</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1e2e65d9-bb14-4b3a-8db0-c52591948c19">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">207476.96</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1fe2a776-20eb-4964-8db2-548f36d0e256">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">147650.77</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="47393cce-2a2a-45d7-bc1a-b48b5b81ac0d">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">193687.59</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3a07276d-bcd0-4f39-b418-c2e20bdd7b0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">158690.85</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0ada6e53-967c-4ebc-a16e-0d7d914df9ae">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-17" />
      <value currency="USD" value-date="2025-04-17">183392.95</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e2c794c2-86ff-43e2-b71c-dfa1d91f4f82">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-13" />
      <value currency="USD" value-date="2025-05-13">1393234.73</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2775a34e-e586-4cf5-8ecc-2ad82b54d147">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-27" />
      <value currency="USD" value-date="2025-05-27">373397.15</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3961d372-1716-4a4a-b40e-7eabb2acf9bd">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-08" />
      <value currency="USD" value-date="2025-07-08">72758.31</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9122433a-539c-4b00-8813-a48e1cc9d9df">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-02" />
      <value currency="USD" value-date="2025-09-02">1163444.98</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3ff374d2-ff53-4846-b0a1-706e8a29ed20">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-02" />
      <value currency="USD" value-date="2025-09-02">24187.20</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="be3d1b01-14e0-4f7d-b561-7a9bfdc18e3b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-22" />
      <value currency="USD" value-date="2025-10-22">2501666.36</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dd8f494e-8422-4e20-b955-c1c093f980a2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-22" />
      <value currency="USD" value-date="2025-10-22">-3831598.36</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a485cc3f-ac32-4cf4-911b-9a6462decb3b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">1428863.58</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0d818dd8-2513-433e-9b1f-3d78bf39847b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">159277.69</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f0bac82-5e50-4b54-b8cf-ccdd6f6eaf30">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">74338.73</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a0b30441-dadb-4e23-91ea-d7728489f7da">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">51003.46</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="889fb44c-46df-40a6-b957-eac2416266f7">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">130407.03</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="345e9b8a-f9ea-43a3-a4e8-6d256858d13f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">38496.12</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="15cfd476-06ed-4486-a2d7-1e3200db75ad">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-10" />
      <value currency="USD" value-date="2025-11-10">228715.35</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d716008c-07cb-427e-b4f1-ac079805af5c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">228715.35</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b3632793-cded-4384-b9bf-440ccb92dc94">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">70214.15</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="30eaf5af-84c4-4c47-8628-4da0df52f2a2">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-09" />
      <value currency="USD" value-date="2026-02-09">-549065.60</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5685c504-54d3-481f-bf99-961e2686ff01">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-09" />
      <value currency="USD" value-date="2026-02-09">3675155.57</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b1906bd6-d8e4-4c93-9142-1de802e40a3e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-17" />
      <value currency="USD" value-date="2026-02-17">3126089.97</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0bfddfa1-23a0-4244-87b7-addcb48923bb">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-24" />
      <value currency="USD" value-date="2026-04-24">5441636.38</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="19414aef-81a3-4dfd-be4a-10a1752c0ae8">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-24" />
      <value currency="USD" value-date="2026-04-24">-549065.60</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fc4cbf3f-3cee-4488-a9fc-d47cea69dc27">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">155311.48</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d804d464-0fa0-4d46-90ea-0ede0e7e671d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">180866.70</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="da512498-8f21-4e47-a06d-b7fa3ff6f7a8">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">137338.05</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dab0471e-4a7a-4979-8937-4764157aa1e4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">70138.95</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e27bad2a-4ba2-44b0-bb5b-c33de18ab32b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">159254.75</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a4b0ed13-2cd3-4617-8b06-ec38154cbe0e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">186846.70</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="94949162-9b1a-48ae-89c9-aedeb1e541ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">163943.96</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="611b28fe-4769-4cda-982f-e650ac3f1603">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-18" />
      <value currency="USD" value-date="2026-08-18">3317939.23</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f5a5220e-39bc-4910-a0f7-e574d284c920">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-18" />
      <value currency="USD" value-date="2026-08-18">143201.10</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f508c95a-81fb-4381-b136-83bf21dfe5bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-15" />
      <value currency="USD" value-date="2026-09-15">17398.04</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="992fce14-afa7-4929-ae63-588e761d5e8a">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-15" />
      <value currency="USD" value-date="2026-09-15">58985.89</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="MLI-C-ARCP02-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">7738193.82</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP02, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MLI-C-ARCP02-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">8016943.32</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP02, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MLI-C-ARC" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MLI/2023/Multicomponent/en/MLI-Z_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 2 - Multicomponent - Mali - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1506-MLI-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-05-30" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MLI/2023/Multicomponent/fr/MLI-Z_FundingRequest_1_fr.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 2 - Multicomponent - Mali - Français</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1506-MLI-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="fr" />
      <document-date iso-date="2023-05-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-5-Other1 Percentage of sex workers newly diagnosed with HIV who were initiated on ART</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-5-Other1 Percentage of sex workers newly diagnosed with HIV who were initiated on ART</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="77.56">
          <comment>
            <narrative>Numerator: 1434; Denominator: 1849.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95.05">
            <comment>
              <narrative>Numerator: 749; Denominator: 788.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1498; Denominator: 1577.</narrative>
            </comment>
          </target>
          <actual value="93.89">
            <comment>
              <narrative>Numerator: 2058; Denominator: 2192.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="94.93">
            <comment>
              <narrative>Numerator: 749; Denominator: 789.</narrative>
            </comment>
          </target>
          <actual value="97.12">
            <comment>
              <narrative>Numerator: 1080; Denominator: 1112.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 781; Denominator: 822.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1563; Denominator: 1645.</narrative>
            </comment>
          </target>
          <actual value="97.31">
            <comment>
              <narrative>Numerator: 1914; Denominator: 1967.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95.02">
            <comment>
              <narrative>Numerator: 782; Denominator: 823.</narrative>
            </comment>
          </target>
          <actual value="99.55">
            <comment>
              <narrative>Numerator: 1100; Denominator: 1105.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95.05">
            <comment>
              <narrative>Numerator: 807; Denominator: 849.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="94.94">
            <comment>
              <narrative>Numerator: 807; Denominator: 850.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-5-Other2 Percentage of MSM newly diagnosed with HIVwho were initiated on ART</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-5-Other2 Percentage of MSM newly diagnosed with HIVwho were initiated on ART</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="90.28">
          <comment>
            <narrative>Numerator: 353; Denominator: 391.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95.1">
            <comment>
              <narrative>Numerator: 504; Denominator: 530.</narrative>
            </comment>
          </target>
          <actual value="89.94">
            <comment>
              <narrative>Numerator: 590; Denominator: 656.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95.09">
            <comment>
              <narrative>Numerator: 252; Denominator: 265.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95.09">
            <comment>
              <narrative>Numerator: 252; Denominator: 265.</narrative>
            </comment>
          </target>
          <actual value="94.43">
            <comment>
              <narrative>Numerator: 322; Denominator: 341.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95.05">
            <comment>
              <narrative>Numerator: 288; Denominator: 303.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95.1">
            <comment>
              <narrative>Numerator: 577; Denominator: 607.</narrative>
            </comment>
          </target>
          <actual value="96.35">
            <comment>
              <narrative>Numerator: 422; Denominator: 438.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95.07">
            <comment>
              <narrative>Numerator: 289; Denominator: 304.</narrative>
            </comment>
          </target>
          <actual value="102.17">
            <comment>
              <narrative>Numerator: 235; Denominator: 230.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95.06">
            <comment>
              <narrative>Numerator: 327; Denominator: 344.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="94.78">
            <comment>
              <narrative>Numerator: 327; Denominator: 345.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 5839; Denominator: 11379; Percentage: 51.31%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 422.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 422.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 2166.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 2166.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 3251.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 3251.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7572; Denominator: 12142; Percentage: 62.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7367; Denominator: 12142; Percentage: 60.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7139; Denominator: 12142; Percentage: 58.8%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7572; Denominator: 12142; Percentage: 62.36%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7367; Denominator: 12142; Percentage: 60.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 380.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 2085.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 4902.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8123; Denominator: 12543; Percentage: 64.76%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8674; Denominator: 12543; Percentage: 69.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7178; Denominator: 12543; Percentage: 57.23%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8674; Denominator: 12543; Percentage: 69.15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7178; Denominator: 12543; Percentage: 57.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 368.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 1575.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 5235.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 9258; Denominator: 12957; Percentage: 71.45%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9841; Denominator: 12957; Percentage: 75.95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 220; Denominator: 428; Percentage: 51.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 20.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 20.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 104.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 104.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 96.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 96.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 262; Denominator: 457; Percentage: 57.33%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 292; Denominator: 457; Percentage: 63.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 305; Denominator: 457; Percentage: 66.74%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 292; Denominator: 457; Percentage: 63.89%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 305; Denominator: 457; Percentage: 66.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 186.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 107.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 309; Denominator: 472; Percentage: 65.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 310; Denominator: 472; Percentage: 65.68%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 294; Denominator: 472; Percentage: 62.29%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 309; Denominator: 472; Percentage: 65.47%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 310; Denominator: 472; Percentage: 65.68%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 22.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 115.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 173.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 314; Denominator: 487; Percentage: 64.48%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 331; Denominator: 487; Percentage: 67.97%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2140; Denominator: 6952; Percentage: 30.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 528.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 528.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1442.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1442.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 146.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 146.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1994.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1994.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2538; Denominator: 7419; Percentage: 34.21%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2671; Denominator: 7419; Percentage: 36%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3269; Denominator: 7419; Percentage: 44.06%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2671; Denominator: 7419; Percentage: 36%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3269; Denominator: 7419; Percentage: 44.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 218.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 1038.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2013.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 446.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2823.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3004; Denominator: 7664; Percentage: 39.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3166; Denominator: 7664; Percentage: 41.31%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2838; Denominator: 7664; Percentage: 37.03%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3004; Denominator: 7664; Percentage: 39.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3166; Denominator: 7664; Percentage: 41.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 177.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 835.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2154.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 399.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2767.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3170; Denominator: 7917; Percentage: 40.04%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3335; Denominator: 7917; Percentage: 42.12%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 21850; Denominator: 23651; Percentage: 92.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 2194.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 2194.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 7560.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 7560.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12086.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12086.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 21840; Denominator: 21664; Percentage: 100.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 21840; Denominator: 21664; Percentage: 100.81%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 22523; Denominator: 25230; Percentage: 89.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23873; Denominator: 25230; Percentage: 94.62%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 22355; Denominator: 25230; Percentage: 88.6%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 22523; Denominator: 25230; Percentage: 89.27%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23873; Denominator: 25230; Percentage: 94.62%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 1890.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 8702.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 13228.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 23873.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23507; Denominator: 26062; Percentage: 90.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24958; Denominator: 26062; Percentage: 95.76%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 23015; Denominator: 26062; Percentage: 88.31%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23507; Denominator: 26062; Percentage: 90.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24958; Denominator: 26062; Percentage: 95.76%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 1897.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 7878.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 15183.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 24958.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 23892; Denominator: 26922; Percentage: 88.75%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 24276; Denominator: 26922; Percentage: 90.17%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="122" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="174" />
          <actual value="223" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="87" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="87" />
          <actual value="108" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="115" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="230" />
          <actual value="216" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="115" />
          <actual value="113" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="146" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="146" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 5839; Denominator: 11379; Percentage: 51.31%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 422.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 422.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 2166.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 2166.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 3251.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 3251.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7971; Denominator: 12142; Percentage: 65.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3810; Denominator: 12142; Percentage: 31.38%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7971; Denominator: 12142; Percentage: 65.65%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3810; Denominator: 12142; Percentage: 31.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 225.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 1018.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2567.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8551; Denominator: 12543; Percentage: 68.17%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9131; Denominator: 12543; Percentage: 72.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7187; Denominator: 12543; Percentage: 57.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9131; Denominator: 12543; Percentage: 72.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7187; Denominator: 12543; Percentage: 57.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 372.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 1581.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 5234.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 9745; Denominator: 12957; Percentage: 75.21%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 10359; Denominator: 12957; Percentage: 79.95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2141; Denominator: 6952; Percentage: 30.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 528.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 528.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1443.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1443.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 146.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 146.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1995.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1995.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2811; Denominator: 7419; Percentage: 37.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1605; Denominator: 7419; Percentage: 21.63%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2811; Denominator: 7419; Percentage: 37.89%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1605; Denominator: 7419; Percentage: 21.63%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 103.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 450.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1052.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 193.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1412.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3162; Denominator: 7664; Percentage: 41.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2865; Denominator: 7664; Percentage: 37.38%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2987; Denominator: 7664; Percentage: 38.97%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3162; Denominator: 7664; Percentage: 41.26%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2865; Denominator: 7664; Percentage: 37.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 156.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 764.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1918.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 364.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2501.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3342; Denominator: 7917; Percentage: 42.21%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3532; Denominator: 7917; Percentage: 44.61%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 21995; Denominator: 23651; Percentage: 93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 2207.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 2207.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 7613.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 7613.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12175.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12175.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 21995; Denominator: 21664; Percentage: 101.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 21995; Denominator: 21664; Percentage: 101.53%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23709; Denominator: 25230; Percentage: 94%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4459; Denominator: 25230; Percentage: 17.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23709; Denominator: 25230; Percentage: 93.97%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4459; Denominator: 25230; Percentage: 17.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 517.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 1599.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2343.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4459.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 24227; Denominator: 26062; Percentage: 92.96%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 24744; Denominator: 26062; Percentage: 94.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 25094; Denominator: 26062; Percentage: 96.29%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 24744; Denominator: 26062; Percentage: 94.94%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 25094; Denominator: 26062; Percentage: 96.29%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 1903.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 7911.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 15280.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 25094.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 25149; Denominator: 26922; Percentage: 93.41%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 25554; Denominator: 26922; Percentage: 94.92%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="14.73">
          <comment>
            <narrative>Numerator: 1163; Denominator: 7897.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="20.01">
            <comment>
              <narrative>Numerator: 871; Denominator: 4353.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="20">
            <comment>
              <narrative>Numerator: 1742; Denominator: 8706.</narrative>
            </comment>
          </target>
          <actual value="18.42">
            <comment>
              <narrative>Numerator: 1176; Denominator: 6386.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="20.01">
            <comment>
              <narrative>Numerator: 871; Denominator: 4353.</narrative>
            </comment>
          </target>
          <actual value="23.02">
            <comment>
              <narrative>Numerator: 739; Denominator: 3210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="25">
            <comment>
              <narrative>Numerator: 2296; Denominator: 9185.</narrative>
            </comment>
          </target>
          <actual value="26.57">
            <comment>
              <narrative>Numerator: 1662; Denominator: 6256.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="25">
            <comment>
              <narrative>Numerator: 1148; Denominator: 4592.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="24.99">
            <comment>
              <narrative>Numerator: 1148; Denominator: 4593.</narrative>
            </comment>
          </target>
          <actual value="27.49">
            <comment>
              <narrative>Numerator: 862; Denominator: 3136.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="24.99">
            <comment>
              <narrative>Numerator: 1211; Denominator: 4845.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="24.99">
            <comment>
              <narrative>Numerator: 1211; Denominator: 4845.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>